Dr. Bae is a dermatologist with Stanford Health Care and a clinical assistant professor of dermatology at Stanford University School of Medicine. He also serves as the assistant chief of quality, experience, and digital health.
Dr. Bae develops comprehensive and compassionate care plans designed to meet the complete medical, surgical, and cosmetic needs of his patients. His clinical interests include prevention and treatment of skin cancer, acne, psoriasis, as well as the full range of general dermatologic skin conditions.
He also focuses on advances in the management of rarer conditions such as Shoshin beriberi, the disease caused by thiamine deficiency, and eosinophilic granulomatosis with polyangiitis. In addition, Dr. Bae has investigated the risks of skin cancer development in organ transplant patients in the United states.
His current research interests include utilizing technology and digital health solutions to expand patients’ access to dermatological care, improving the quality of care delivery, and enhancing the dermatological care experience for patients.
He has co-authored peer reviewed publications on a broad range of topics from managing rare dermatological conditions to the state of diversity within the field of academic dermatology and issues pertaining to dermatology education and mentorship. His work has appeared in the Journal of the American Academy of Dermatology, Journal of the American Medical Association, American Journal of Medicine, Journal of Cutaneous Pathology, and elsewhere.
Dr. Bae has made numerous presentations both in front of national and international audiences on various topics including autoimmune response to facial silicone injections, innovations in the laser treatment of actinic chelitis, scalp melanoma, and many other topics. He has presented at meetings of the American Academy of Dermatology, Cosmetic Surgery Forum, Association of Professors of Dermatology, and elsewhere.
Among his honors, Dr. Bae received an American Academy of Dermatology international travel grant, a Stanford Society of Physician Scholars grant, and the American Academy of Dermatology Transplant Skin Center fellowship.
Dr. Bae is a member of the American Academy of Dermatology, the American Medical Association, and the Alpha Omega Alpha Medical Honor Society. He is also the founder of Refresh Bolivia, a non-profit organization serving the public health needs of underprivileged communities in Cochabamba, Bolivia.
Clinical Assistant Professor, Dermatology
Assistant Chief of Quality, Experience, and Digital Health, Stanford Department of Dermatology (2020 - Present)
Board Certification: American Board of Dermatology, Dermatology (2020)
Chief Resident, Stanford University (2020)
Residency, Stanford University (2020)
Internship, Brigham and Women's Hospital (2017)
MD, Harvard Medical School (2016)
BA, Harvard College, Summa Cum Laude (2012)
Community and International Work
Refresh Bolivia, Cochabamba, Bolivia
Development of an integrated health center, building ecological toilets, public health education
SOE Univalle, Fundación Nuqanchik, Serve Abroad, Ford College Community Challenge
Opportunities for Student Involvement
- Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers. JAMA dermatology 2022
Shoshin beriberi in a patient with oral and cutaneous graft-versus-host disease
JAAD Case Reports
2020; 6 (5): 420-421
View details for DOI 10.1016/j.jdcr.2020.02.031
- Angiodestructive lymphomatoid papulosis lasting more than 45years. JAAD case reports 2019; 5 (9): 767–69
Sex and Racial/Ethnic Diversity of US Medical Students and Their Exposure to Dermatology Programs.
View details for PubMedID 30649132
Eosinophilic granulomatosis with polyangiitis: histopathological confirmation despite negative serology.
The American journal of medicine
View details for PubMedID 31100285
Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
2017; 153 (3): 296-303
Skin cancer is the most common malignancy occurring after organ transplantation. Although previous research has reported an increased risk of skin cancer in solid organ transplant recipients (OTRs), no study has estimated the posttransplant population-based incidence in the United States.To determine the incidence and evaluate the risk factors for posttransplant skin cancer, including squamous cell carcinoma (SCC), melanoma (MM), and Merkel cell carcinoma (MCC) in a cohort of US OTRs receiving a primary organ transplant in 2003 or 2008.This multicenter retrospective cohort study examined 10 649 adult recipients of a primary transplant performed at 26 centers across the United States in the Transplant Skin Cancer Network during 1 of 2 calendar years (either 2003 or 2008) identified through the Organ Procurement and Transplantation Network (OPTN) database. Recipients of all organs except intestine were included, and the follow-up periods were 5 and 10 years.Incident skin cancer was determined through detailed medical record review. Data on predictors were obtained from the OPTN database. The incidence rates for posttransplant skin cancer overall and for SCC, MM, and MCC were calculated per 100 000 person-years. Potential risk factors for posttransplant skin cancer were tested using multivariate Cox regression analysis to yield adjusted hazard ratios (HR).Overall, 10 649 organ transplant recipients (mean [SD] age, 51  years; 3873 women [36%] and 6776 men [64%]) contributed 59 923 years of follow-up. The incidence rates for posttransplant skin cancer was 1437 per 100 000 person-years. Specific subtype rates for SCC, MM, and MCC were 812, 75, and 2 per 100 000 person-years, respectively. Statistically significant risk factors for posttransplant skin cancer included pretransplant skin cancer (HR, 4.69; 95% CI, 3.26-6.73), male sex (HR, 1.56; 95% CI, 1.34-1.81), white race (HR, 9.04; 95% CI, 6.20-13.18), age at transplant 50 years or older (HR, 2.77; 95% CI, 2.20-3.48), and being transplanted in 2008 vs 2003 (HR, 1.53; 95% CI, 1.22-1.94).Posttransplant skin cancer is common, with elevated risk imparted by increased age, white race, male sex, and thoracic organ transplantation. A temporal cohort effect was present. Understanding the risk factors and trends in posttransplant skin cancer is fundamental to targeted screening and prevention in this population.
View details for DOI 10.1001/jamadermatol.2016.4920
View details for PubMedID 28097368
Creation and evaluation of a topical steroid therapy educational video for atopic dermatitis
MOSBY-ELSEVIER. 2016: AB86
View details for Web of Science ID 000412760201240
- Changes in sex and racial diversity in academic dermatology faculty over 20 years. Journal of the American Academy of Dermatology 2016; 75 (6): 1252–54
- Comparing dermatology referral patterns and diagnostic accuracy between nonphysician providers, physician trainees, and attending physicians. Journal of the American Academy of Dermatology 2016; 75 (1): 226–27
- Changes in Sex and Ethnic Diversity in Dermatology Residents Over Multiple Decades. JAMA dermatology 2016; 152 (1): 92–94
- Rapidly progressive nonuremic calciphylaxis in the setting of warfarin. The American journal of medicine 2015; 128 (10): e19–21
- Evanescent, episodic salmon-colored macules in a young woman. JAAD case reports 2022; 29: 30-32
- Burning urticarial plaques in a middle-aged woman. JAAD case reports 2022; 28: 138-141
- From Tiger Grip to Loma Linda Loop: Helpful ways to cinch knots under traction. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022
- Nontender white papule of the areola in a middle-aged female. JAAD case reports 2022; 27: 6-8
- Vom Tiger-Griff zur Loma-Linda-Schlaufe: Hilfreiche Techniken zum Knoten unter Zug. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; 20 (9): 1243-1246
- New-onset pemphigus vegetans and pemphigus foliaceus following SARS-CoV-2 vaccination: a case series. JAAD case reports 2022
- The Smartphone Hanger A Simple Tool for Recording Live Hands-On Demonstrations JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION 2022; 14 (3): 131-132
The sunscreen for kindergarteners (SKIN) study trial protocol.
Contemporary clinical trials
BACKGROUND: Exposure to ultraviolet radiation (UVR) is the major modifiable risk factor for skin cancers. The majority of lifetime UVR exposure occurs before age 20, underscoring an important window for risk reduction. Incorporation of skills-based sunscreen education into school health curricula may foster the development of consistent and effective use of sunscreen among children and youth. We describe the study protocol for a first-of-its-kind study that examined the feasibility of bringing skills-based sunscreen education into kindergarten classrooms.METHODS: Participants were 96 kindergarten students across four classrooms in a single elementary school. A single-blind open-label trial design was used to evaluate the feasibility of incorporating a song-based, video-guided intervention for independent application of sunscreen into the kindergarten curriculum. Students first completed a 10-day no-intervention baseline period, followed by a 10-day intervention period, and then a 10-day randomized follow-up period where students were randomly assigned to continue with the intervention or to revert to the no-intervention condition.OUTCOMES: Feasibility metrics associated with study process, resources, management, scientific outcomes and safety were gathered. The primary outcome was pre-to-post intervention changes in student engagement in the sunscreen task. The secondary outcome was pre-to-post intervention changes in the proportion of exposed skin to which a student applies sunscreen. Teacher and student perceptions of intervention value and utility were also evaluated.DISCUSSION: This is the study protocol for a clinical trial designed to determine the feasibility of implementing a skills-based sunscreen curriculum in kindergarten classrooms. Next steps include evaluation of the intervention for efficacy and effectiveness.CLINICAL TRIAL REGISTRATION: NCT03752736.
View details for DOI 10.1016/j.cct.2021.106480
View details for PubMedID 34126263
Subcorneal pustular dermatosis associated with IgG monoclonal gammopathy of undetermined significance.
Dermatology online journal
2021; 27 (4)
Subcorneal pustular dermatosis is a rare chronic relapsing bullous neutrophilic dermatosis. Because it can be associated with monoclonal gammopathy of undetermined significance and multiple myeloma, screening for these conditions is necessary. Herein, we present a case of subcorneal pustular dermatosis, with concurrent monoclonal gammopathy of undetermined significance, successfully treated with acitretin.
View details for PubMedID 33999577
- Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome. JAAD case reports 2021; 9: 42–44
Reactivation of Chagas Disease in a Patient With an Autoimmune Rheumatic Disease: Case Report and Review of the Literature.
Open forum infectious diseases
2021; 8 (2): ofaa642
Reactivation of Chagas disease has been described in immunosuppressed patients, but there is a paucity of literature describing reactivation in patients on immunosuppressive therapies for the treatment of autoimmune rheumatic diseases. We describe a case of Chagas disease reactivation in a woman taking azathioprine and prednisone for limited cutaneous systemic sclerosis (lcSSc). Reactivation manifested as indurated and erythematous cutaneous nodules. Sequencing of a skin biopsy specimen confirmed the diagnosis of Chagas disease. She was treated with benznidazole with clinical improvement in the cutaneous lesions. However, her clinical course was complicated and included disseminated CMV disease and subsequent septic shock due to bacteremia. Our case and review of the literature highlight that screening for Chagas disease should be strongly considered for patients who will undergo immunosuppression for treatment of autoimmune disease if epidemiologically indicated.
View details for DOI 10.1093/ofid/ofaa642
View details for PubMedID 33575423
View details for PubMedCentralID PMC7863873
Concurrent Trypanosoma cruzi and Cytomegalovirus Reactivation in an Immunosuppressed Patient With Limited Cutaneous Systemic Sclerosis.
The American Journal of dermatopathology
Chagas disease, a multisystem infection caused by the protozoan Trypanosoma cruzi, is primarily found in Latin America. In recent years, prevalence has increased in the United States, where reactivation is the most common clinical scenario. Here, we describe cutaneous reactivation of T. cruzi in a patient with limited cutaneous systemic sclerosis on immunosuppression therapy who simultaneously presented with cytomegalovirus reactivation. Histopathology showed parasitized histiocytes in the superficial and deep dermis. Occasional epidermal keratinocytes were also parasitized, and rare organisms were also seen in the walls of blood vessels. Also noted were viral cytopathic changes within the vascular endothelium, and immunostaining confirmed cytomegalovirus. In this report, we describe the difference in cutaneous findings between reactivated and acute Chagas disease, and we also review the histopathologic features that help distinguish T.cruzi from other intracellular organisms.
View details for DOI 10.1097/DAD.0000000000001842
View details for PubMedID 33201010
- Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing. JAAD case reports 2020; 6 (11): 1156–58
- The Reply. The American journal of medicine 2019; 132 (11): e812
Pachydermodactyly: case report including clinical and histopathologic diagnostic pitfalls.
Journal of cutaneous pathology
Pachydermodactyly is a rare, benign condition characterized by swelling and thickening of the periarticular skin, most commonly at the proximal interphalangeal joints. Diagnosis is routinely made through correlation of clinical, histopathologic, and radiographic findings. Here we report a case of pachydermodactyly in a 25 year-old male, with emphasis on the clinical and histopathologic differential diagnosis and potential diagnostic pitfalls. This article is protected by copyright. All rights reserved.
View details for PubMedID 30221379
Gender and Ethnic Diversity in Academic PM&R Faculty: National Trend Analysis of Two Decades
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
2017; 96 (8): 593–95
Over the years, a number of studies have demonstrated an increase in gender and ethnic diversity among US physicians. Despite substantial progress in eliminating gender and racial inequities in the field of medicine, women and ethnic minorities are still underrepresented among medical faculty at academic institutions. This study aims to describe the trends in gender and ethnic diversity among Physical Medicine and Rehabilitation (PM&R) faculty through statistical analysis of data describing gender and ethnicity of full-time academic faculty gathered from the Association of American Medical Colleges Faculty Roster from 1994 to 2014. Proportions representing the percentages of females and ethnic minorities of a given faculty position in medical schools were compared across each of the other faculty ranks. Results showed that the average yearly percent increases in the proportion of female PM&R faculty in associate professor (0.68%) and full professor (0.54%) positions were greater than those in instructor (0.30%) and assistant professor (0.35%) positions. In contrast, the average yearly percent increase in the proportion of non-Caucasian PM&R faculty in full professor positions (0.19%) was less than those in instructor (0.84%), assistant (0.93%), and associate professor (0.89%) positions. Overall, trends among faculty exhibit a steady increase in gender and ethnic diversity, although promotion disparity continues to exist among specific academic positions for some groups. This study provides a current perspective on recent changes in diversity among faculty in PM&R and may prove useful when defining strategies to improve workforce diversity.
View details for DOI 10.1097/PHM.0000000000000716
View details for Web of Science ID 000405783800011
View details for PubMedID 28169861
Ethnic and Gender Diversity in Hand Surgery Trainees
JOURNAL OF HAND SURGERY-AMERICAN VOLUME
2015; 40 (4): 790–97
To evaluate whether the lack of diversity in plastic and orthopedic surgery persists into hand surgery through assessment of trainee demographics.Demographic data were obtained from compilations on graduate medical education by the Journal of the American Medical Association. Ethnic diversity was assessed using the proportions of minority trainees. We analyzed the trends in ethnic diversity in hand, orthopedic, and plastic surgery from 1995 to 2012 by evaluating changes in proportions of African American, Hispanic, and Asian trainees. In addition, we compared the proportions of minority trainees in various surgical specialties during 2009 to 2012. Trends in gender diversity were similarly analyzed using the proportions of female trainees.During 1995 to 2012, the proportions of minority and female trainees increased significantly in the fields of orthopedic, plastic, and hand surgery. To assess the current state of diversity in various specialties, we compared minority and female population proportions using pooled 2009 to 2012 data. The percentage of non-Caucasian trainees in hand surgery was significantly higher than that in orthopedic sports medicine and orthopedic surgery and significantly lower than in general surgery. The percentage of female trainees in hand surgery was significantly higher than that in orthopedic sports medicine and orthopedic surgery and significantly lower than in plastic and general surgery.Ethnic and gender diversity in hand surgery increased significantly between 1995 and 2012. Women constitute a fifth of hand surgery trainees. Efforts to increase diversity should be further pursued using proven strategies and innovating new ones.Diversity in the medical field has shown to be a beneficial factor in many aspects including research productivity and patient care. Understanding how the field of hand surgery has changed with regard to the diversity of its trainees may aid in providing more equitable and effective health care.
View details for DOI 10.1016/j.jhsa.2014.10.065
View details for Web of Science ID 000352521000024
View details for PubMedID 25639841
A 20-YEAR ANALYSIS OF HAND AND WRIST RESEARCH PRODUCTIVITY IN ASIA
JOURNAL OF HAND SURGERY-ASIAN-PACIFIC VOLUME
2014; 19 (2): 211–16
Bibliometric analyses of the hand and wrist research have previously shown a significant increase in research productivity in Asia. We examined the key contributors to this change by performing bibliometric analyses regarding hand and wrist research in all Asian countries producing significant research. Original research articles from 1988 to 2007 were collected from seven English language journals based on the impact factor. Trends in research productivity were determined by country using linear regression analysis. Compared to the rest of the world, Asia produced fewer level I and basic studies, but more level IV studies. Significant increase in both research volume and productivity in Asia was observed, with Japan, Korea, and Taiwan having the highest aggregate productivity in hand and wrist research. From 1988 to 2007, the relative research production among Asian countries showed significant change, in contrary to that of Europe, Latin American, and the United States.
View details for DOI 10.1142/S0218810414500221
View details for Web of Science ID 000216855400010
View details for PubMedID 24875505
Acetic acid iontophoresis for recalcitrant scarring in post-operative hand patients.
Journal of hand therapy : official journal of the American Society of Hand Therapists
2013; 27 (1): 44–48
Retrospective cohort comparison.Using acetic acid iontophoresis (AAI) as a treatment modality significantly improved the functionality of hand in patients with recalcitrant scarring.Open trigger finger release patients followed up exclusively at a hand clinic between 2009 and 2011 were analyzed. Group I recovered optimal total active range of motion (TAM) after 14 standard of care (SOC) therapy sessions but Group II (10 digits) could only reach optimal recovery after 7 additional AAI sessions.After SOC therapy, Group I's TAM recovery plateaued at 245 and Group II's at 219 (p < 0.01). After undergoing AAI, the TAM of Group II increased from 219 to 239 (p < 0.01).Clinical studies suggest that AAI can modify collagen structure in scars. AAI could be a novel non-surgical treatment for restoring functionality to areas affected by difficult, recalcitrant scars.AAI significantly improved the TAM of hand surgical patients who could not recover optimally with SOC therapy alone.Level 3.
View details for DOI 10.1016/j.jht.2013.10.008
View details for PubMedID 24373451
- Topical Steroid Therapy Educational Video for Eczema. Dermatitis : contact, atopic, occupational, drug ; 27 (3): 157–58